BIOGEN INC. Capital Expenditures
BIOGEN INC. (BIIB) reported Capital Expenditures of $51.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-04-29
- BIOGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $51.20M, a 38.01% increase year-over-year.
- BIOGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $43.90M, a 11.70% increase year-over-year.
- BIOGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $46.20M, a 32.00% increase year-over-year.
- BIOGEN INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $26.60M, a 20.60% decline year-over-year.
- BIOGEN INC. payments to acquire property, plant, and equipment for fiscal 2025 was $153.80M, a 0.07% increase from fiscal 2024.
- BIOGEN INC. payments to acquire property, plant, and equipment for fiscal 2024 was $153.70M, a 44.51% decline from fiscal 2023.
- BIOGEN INC. payments to acquire property, plant, and equipment for fiscal 2023 was $277.00M, a 15.27% increase from fiscal 2022.
- BIOGEN INC. payments to acquire property, plant, and equipment for fiscal 2022 was $240.30M, a 6.90% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $51.20M 10-Q · filed 2026-04-29 | $95.10M derived: sum of 2 quarters · filed 2026-04-29 | $141.30M derived: sum of 3 quarters · filed 2026-04-29 | $167.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $43.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $90.10M derived: sum of 2 quarters · filed 2026-02-06 | $116.70M derived: sum of 3 quarters · filed 2026-02-06 | $153.80M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $46.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $72.80M derived: sum of 2 quarters · filed 2025-10-30 | $109.90M 10-Q · filed 2025-10-30 | $149.20M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $26.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $63.70M 10-Q · filed 2025-07-31 | $103.00M derived: sum of 3 quarters · filed 2026-04-29 | $138.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $37.10M 10-Q · filed 2026-04-29 | $76.40M derived: sum of 2 quarters · filed 2026-04-29 | $111.40M derived: sum of 3 quarters · filed 2026-04-29 | $144.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $39.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $74.30M derived: sum of 2 quarters · filed 2026-02-06 | $107.80M derived: sum of 3 quarters · filed 2026-02-06 | $153.70M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $68.50M derived: sum of 2 quarters · filed 2025-10-30 | $114.40M 10-Q · filed 2025-10-30 | $179.60M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $33.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $79.40M 10-Q · filed 2025-07-31 | $144.60M derived: sum of 3 quarters · filed 2026-02-06 | $218.80M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $45.90M 10-Q · filed 2025-05-01 | $111.10M derived: sum of 2 quarters · filed 2026-02-06 | $185.30M derived: sum of 3 quarters · filed 2026-02-06 | $256.30M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $65.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $139.40M derived: sum of 2 quarters · filed 2026-02-06 | $210.40M derived: sum of 3 quarters · filed 2026-02-06 | $277.00M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $74.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $145.20M derived: sum of 2 quarters · filed 2024-10-30 | $211.80M 10-Q · filed 2024-10-30 | $298.20M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $71.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $137.60M 10-Q · filed 2024-08-01 | $224.00M derived: sum of 3 quarters · filed 2025-02-12 | $283.10M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $66.60M 10-Q · filed 2024-04-24 | $153.00M derived: sum of 2 quarters · filed 2025-02-12 | $212.10M derived: sum of 3 quarters · filed 2025-02-12 | $249.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $86.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $145.50M derived: sum of 2 quarters · filed 2025-02-12 | $182.40M derived: sum of 3 quarters · filed 2025-02-12 | $240.30M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $59.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $96.00M derived: sum of 2 quarters · filed 2023-11-08 | $153.90M 10-Q · filed 2023-11-08 | $205.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $36.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $94.80M 10-Q · filed 2023-07-25 | $146.40M derived: sum of 3 quarters · filed 2024-02-14 | $188.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $57.90M 10-Q · filed 2023-04-25 | $109.50M derived: sum of 2 quarters · filed 2024-02-14 | $151.50M derived: sum of 3 quarters · filed 2024-02-14 | $223.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $51.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $93.60M derived: sum of 2 quarters · filed 2024-02-14 | $165.50M derived: sum of 3 quarters · filed 2024-02-14 | $258.10M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $113.90M derived: sum of 2 quarters · filed 2022-10-25 | $206.50M 10-Q · filed 2022-10-25 | $292.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $71.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $164.50M 10-Q · filed 2022-07-20 | $250.50M derived: sum of 3 quarters · filed 2023-02-15 | $334.60M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $92.60M 10-Q · filed 2022-05-03 | $178.60M derived: sum of 2 quarters · filed 2023-02-15 | $262.70M derived: sum of 3 quarters · filed 2023-02-15 | $367.70M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $86.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $170.10M derived: sum of 2 quarters · filed 2023-02-15 | $275.10M derived: sum of 3 quarters · filed 2023-02-15 | $424.80M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $84.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $189.10M derived: sum of 2 quarters · filed 2021-10-20 | $338.80M 10-Q · filed 2021-10-20 | $449.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $105.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $254.70M 10-Q · filed 2021-07-22 | $365.10M derived: sum of 3 quarters · filed 2022-02-03 | $455.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $149.70M 10-Q · filed 2021-04-22 | $260.10M derived: sum of 2 quarters · filed 2022-02-03 | $350.20M derived: sum of 3 quarters · filed 2022-02-03 | $537.10M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $110.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $200.50M derived: sum of 2 quarters · filed 2022-02-03 | $387.40M derived: sum of 3 quarters · filed 2022-02-03 | $514.50M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $90.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $277.00M derived: sum of 2 quarters · filed 2020-10-21 | $404.10M 10-Q · filed 2020-10-21 | $630.00M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $186.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $314.00M 10-Q · filed 2020-07-22 | $539.90M derived: sum of 3 quarters · filed 2021-02-03 | $703.10M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $127.10M 10-Q · filed 2020-04-23 | $353.00M derived: sum of 2 quarters · filed 2021-02-03 | $516.20M derived: sum of 3 quarters · filed 2021-02-03 | $703.00M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $225.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $389.10M derived: sum of 2 quarters · filed 2021-02-03 | $575.90M derived: sum of 3 quarters · filed 2021-02-03 | $770.60M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $163.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $350.00M derived: sum of 2 quarters · filed 2019-10-22 | $544.70M 10-Q · filed 2019-10-22 | $775.30M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $186.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $381.50M 10-Q · filed 2019-07-24 | $612.10M derived: sum of 3 quarters · filed 2020-02-06 | $841.20M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $194.70M 10-Q · filed 2019-04-24 | $425.30M derived: sum of 2 quarters · filed 2020-02-06 | $654.40M derived: sum of 3 quarters · filed 2020-02-06 | $852.10M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $230.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $459.70M derived: sum of 2 quarters · filed 2020-02-06 | $657.40M derived: sum of 3 quarters · filed 2020-02-06 | $867.40M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $229.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $426.80M derived: sum of 2 quarters · filed 2018-10-23 | $636.80M 10-Q · filed 2018-10-23 | $818.90M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $197.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $407.70M 10-Q · filed 2018-07-24 | $589.80M derived: sum of 3 quarters · filed 2019-02-06 | $760.10M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $210.00M 10-Q · filed 2018-04-24 | $392.10M derived: sum of 2 quarters · filed 2019-02-06 | $562.40M derived: sum of 3 quarters · filed 2019-02-06 | $699.20M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $182.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $352.40M derived: sum of 2 quarters · filed 2019-02-06 | $489.20M derived: sum of 3 quarters · filed 2019-02-06 | $616.10M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $170.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $307.10M derived: sum of 2 quarters · filed 2017-10-24 | $434.00M 10-Q · filed 2017-10-24 | $620.10M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $136.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $263.70M 10-Q · filed 2017-07-25 | $449.80M derived: sum of 3 quarters · filed 2018-02-01 | $679.00M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $126.90M 10-Q · filed 2017-04-25 | $313.00M derived: sum of 2 quarters · filed 2018-02-01 | $542.20M derived: sum of 3 quarters · filed 2018-02-01 | $672.10M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $186.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $415.30M derived: sum of 2 quarters · filed 2018-02-01 | $545.20M derived: sum of 3 quarters · filed 2018-02-01 | $643.00M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $229.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $359.10M derived: sum of 2 quarters · filed 2016-10-26 | $456.90M 10-Q · filed 2016-10-26 | $456.88M 10-Q · filed 2015-10-21 | $563.85M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $129.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $227.70M 10-Q · filed 2016-07-21 | $227.69M 10-Q · filed 2015-07-24 | $334.65M derived: sum of 3 quarters · filed 2017-02-02 | $397.19M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $97.80M 10-Q · filed 2016-04-21 | $97.83M 10-Q · filed 2015-04-24 | $204.75M derived: sum of 2 quarters · filed 2017-02-02 | $267.29M derived: sum of 3 quarters · filed 2017-02-02 | $331.29M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $106.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $169.49M derived: sum of 2 quarters · filed 2017-02-02 | $233.49M derived: sum of 3 quarters · filed 2017-02-02 | $287.80M 10-K · filed 2017-02-02 | $287.75M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $62.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $126.55M derived: sum of 2 quarters · filed 2015-10-21 | $180.85M 10-Q · filed 2015-10-21 | $259.53M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $118.31M 10-Q · filed 2015-07-24 | $196.98M derived: sum of 3 quarters · filed 2016-02-03 | $277.17M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $54.31M 10-Q · filed 2015-04-24 | $132.98M derived: sum of 2 quarters · filed 2016-02-03 | $213.17M derived: sum of 3 quarters · filed 2016-02-03 | $267.32M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $78.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $158.86M derived: sum of 2 quarters · filed 2016-02-03 | $213.01M derived: sum of 3 quarters · filed 2016-02-03 | $246.30M 10-K · filed 2016-02-03 | $246.28M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $80.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $134.34M derived: sum of 2 quarters · filed 2014-10-22 | $167.63M 10-Q · filed 2014-10-22 | $236.66M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $54.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $87.44M 10-Q · filed 2014-07-23 | $156.48M derived: sum of 3 quarters · filed 2015-02-04 | $214.54M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $33.29M 10-Q · filed 2014-04-23 | $102.33M derived: sum of 2 quarters · filed 2015-02-04 | $160.39M derived: sum of 3 quarters · filed 2015-02-04 | $233.29M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $69.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $127.10M derived: sum of 2 quarters · filed 2015-02-04 | $200.00M derived: sum of 3 quarters · filed 2015-02-04 | $254.55M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $58.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $130.96M derived: sum of 2 quarters · filed 2013-10-28 | $185.51M 10-Q · filed 2013-10-28 | $255.95M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $72.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $127.45M 10-Q · filed 2013-07-25 | $197.89M derived: sum of 3 quarters · filed 2014-02-06 | $249.24M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $54.55M 10-Q · filed 2013-04-25 | $124.99M derived: sum of 2 quarters · filed 2014-02-06 | $176.34M derived: sum of 3 quarters · filed 2014-02-06 | $230.43M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $70.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $121.79M derived: sum of 2 quarters · filed 2014-02-06 | $175.88M derived: sum of 3 quarters · filed 2014-02-06 | $208.02M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $51.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $105.44M derived: sum of 2 quarters · filed 2012-10-25 | $137.58M 10-Q · filed 2012-10-25 | $186.41M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $54.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $86.23M 10-Q · filed 2012-07-24 | $135.06M derived: sum of 3 quarters · filed 2013-02-05 | $174.02M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $32.14M 10-Q · filed 2012-05-01 | $80.98M derived: sum of 2 quarters · filed 2013-02-05 | $119.94M derived: sum of 3 quarters · filed 2013-02-05 | $166.99M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $48.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $87.80M derived: sum of 2 quarters · filed 2013-02-05 | $134.85M derived: sum of 3 quarters · filed 2013-02-05 | $173.06M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $38.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $86.01M derived: sum of 2 quarters · filed 2011-10-28 | $124.22M 10-Q · filed 2011-10-28 | $179.74M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $47.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $85.26M 10-Q · filed 2011-07-26 | $140.78M derived: sum of 3 quarters · filed 2012-02-03 | $179.19M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $38.21M 10-Q · filed 2011-04-21 | $93.73M derived: sum of 2 quarters · filed 2012-02-03 | $132.13M derived: sum of 3 quarters · filed 2012-02-03 | $166.81M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $55.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $93.92M derived: sum of 2 quarters · filed 2012-02-03 | $128.60M derived: sum of 3 quarters · filed 2012-02-03 | $165.65M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $38.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $73.09M derived: sum of 2 quarters · filed 2010-10-26 | $110.13M 10-Q · filed 2010-10-26 | $164.12M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | $34.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | $71.72M 10-Q · filed 2010-07-20 | -$71.72M 10-Q · filed 2009-07-17 | $125.71M derived: sum of 3 quarters · filed 2011-02-04 | $504.77M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | $37.04M 10-Q · filed 2010-04-20 | $91.03M derived: sum of 2 quarters · filed 2011-02-04 | $470.09M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | $53.99M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $433.05M derived: sum of 2 quarters · filed 2011-02-04 | $275.95M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | $379.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $221.96M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | -$157.09M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | $284.11M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |